首页> 外文期刊>Indian journal of clinical biochemistry >Reference intervals for serum total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Lp (a), apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy South Indians from Andhra Pradesh
【24h】

Reference intervals for serum total cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, Lp (a), apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy South Indians from Andhra Pradesh

机译:在安得拉邦健康的南印度人中,血清总胆固醇,HDL-胆固醇,LDL-胆固醇,甘油三酸酯,Lp(a),载脂蛋白A-I,A-II,B,C-II,C-III和E的参考间隔

获取原文
           

摘要

The incidence of cardiovascular and cerebrovascular disease is steadily increasing in South East Asian countries including Indian sub continent. Many lipids, apolipoproteins and Lp (a) except HDL-C and apo A-I, A-II are implicated as risk factors for coronary artery disease and cerebrovascular disease. There is great need to have national guidelines for each country like the ATP III guidelines recommended for U.S. population. For recommending appropriate medical decision limits, it is mandatory that each country establishes reference intervals pertaining to their population due to dietary, genetic and environmental diversity. In the present study, reference intervals for serum lipids, apolipoproteins and Lp (a) were established in a total of 1923 healthy Indian reference individuals comprising 1161 healthy men and 762 healthy women from Andhra Pradesh. For each analyte viz., serum total cholesterol, HDL-C, LDL-C, triglycerides, Lp (a), Apo A-I, Apo A-II, B, C-II, C-III and E, mean, two SD, median, confidence limits of mean, different percentile values are presented. The study also includes decade wise changes in each analyte and comparison of lipids, lipoproteins and Lp (a) among few populations covering U.S., India, Japan, Sweden, Finland and China. Reference Intervals for all lipid and lipoprotein parameters will immensely help in assessing associated risk for cardiovascular and cerebrovascular diseases in India. Additionally, the results will be beneficial in formulating our own guidelines pertaining to Indian population.
机译:在包括印度次大陆在内的东南亚国家,心血管和脑血管疾病的发病率正在稳步上升。除了HDL-C和载脂蛋白A-I,A-II外,许多脂质,载脂蛋白和Lp(a)也被认为是冠状动脉疾病和脑血管疾病的危险因素。迫切需要为每个国家/地区制定国家指南,例如为美国人口推荐的ATP III指南。为了建议适当的医疗决策限制,由于饮食,遗传和环境的多样性,每个国家都必须建立与本国人口有关的参考间隔。在本研究中,在总共1923名健康的印度参考个体中建立了血脂,载脂蛋白和Lp(a)的参考区间,包括来自安得拉邦的1161名健康男性和762名健康女性。对于每种分析物,血清总胆固醇,HDL-C,LDL-C,甘油三酸酯,Lp(a),Apo AI,Apo A-II,B,C-II,C-III和E,均是两个SD,提供了中位数,均值的置信限,不同的百分数值。该研究还包括每种分析物十年来的变化以及脂,脂蛋白和Lp(a)在美国,印度,日本,瑞典,芬兰和中国的少数人群中的比较。所有脂质和脂蛋白参数的参考时间间隔将极大地帮助评估印度心血管和脑血管疾病的相关风险。此外,结果将有助于制定我们自己的有关印度人口的准则。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号